WASHINGTON--(BUSINESS WIRE)--April 4, 2006--Invitrogen Corporation (Nasdaq:IVGN - News), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the introduction of two new products, GIBCO® functional labels and Omnia(TM) Kinase Assays. Invitrogen also announced that it was recognized by the life sciences industry at The Scientists’ Life Science Industry Awards held at AACR, winning awards in seven categories.
